Tiziana Life Sciences
TLSA
23 hedge funds and large institutions have $14.1M invested in Tiziana Life Sciences in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 10 closing their positions.
350% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 2
9% more capital invested
Capital invested by funds: $12.9M → $14.1M (+$1.2M)
0.67% less ownership
Funds ownership: 3.29% → 2.62% (-0.67%)
4% less funds holding
Funds holding: 24 → 23 (-1)
10% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 10
50% less call options, than puts
Call options by funds: $52K | Put options by funds: $104K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$619K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$115K |
| 3 |
State Street
Boston,
Massachusetts
|
+$51.4K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$49.3K |
| 5 |
AFP
Ausdal Financial Partners
Davenport,
Iowa
|
+$45.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
-$2.18M |
| 2 |
Renaissance Technologies
New York
|
-$1.03M |
| 3 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$90K |
| 4 |
D.E. Shaw & Co
New York
|
-$84K |
| 5 |
VF
Virtu Financial
New York
|
-$67K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VF
26
Virtu Financial
New York
| – | -$67K | -33,232 | Closed |
|
27
Two Sigma Advisers
New York
| – | -$45K | -22,300 | Closed |
|
|
GG
28
Golden Green
Seneca,
South Carolina
| – | -$44K | -21,949 | Closed |
|
|
CS
29
Credit Suisse
Zurich,
Switzerland
| – | -$40K | -20,000 | Closed |
|
30
Millennium Management
New York
| – | -$36K | -17,972 | Closed |
|
31
Goldman Sachs
New York
| – | -$29K | -14,566 | Closed |
|
|
CCMW
32
Cypress Capital Management (Wyoming)
Sheridan,
Wyoming
| – | +$17 | +5 | New |
|
TLSA Hedge Fund Activity: Q1 2021 in Review
23 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Tiziana Life Sciences (TLSA) for Q1 2021, worth a combined $14.1M — up 9.2% from $12.9M a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of TLSA and 9 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 9 added.
The largest buyer was Marshall Wace, opening a new position worth an estimated $619K. The largest seller was Altium Capital Management, exiting entirely with an estimated $2.18M sold.
- 23 institutional investors held Tiziana Life Sciences (TLSA) as of Q1 2021, down from 24 in Q4 2020.
- Funds reported $14.1M of Tiziana Life Sciences stock for Q1 2021, up 9.2% quarter-over-quarter.
- 9 funds opened new Tiziana Life Sciences positions in Q1 2021 and 10 closed out, a net change of -1 holder.
- The largest Tiziana Life Sciences buyer in Q1 2021 was Marshall Wace, an estimated $619K added.
- The largest Tiziana Life Sciences seller in Q1 2021 was Altium Capital Management, an estimated $2.18M sold.
Based on aggregated 13F filings for Q1 2021.